Business
Chemplus, TWC add two new pharmacies as retail sales grow
The combined weight of Chemplus and the Terry White Group has seen the South Australian-based network reporting increased retail sales and the addition of two new pharmacies. The Terry White …
Terry White Group boasts retail sales jump
Terry White Group has announced the network’s first half (to 31 December 2015) retail sales had increased 18%, outperforming the industry average growth rate significantly. Terry White Group CEO Anthony …
EBOS Group acquires Red Seal
EBOS Group Limited has entered into an agreement to acquire a leading New Zealand natural health products business, Red Seal, for NZ$80 million substantially bolstering the Group’s existing position in …
Social media in pharmacy: the good, the bad and the ugly
How to use social media such as Facebook, websites and twitter effectively in pharmacy and ensure all staff understand your social media policy.
Jane McKellar joins TWG Board
Terry White Group has announced the appointment of Jane McKellar to its Board as an Independent Non-Executive Director. McKellar has more than 30 years’ international experience in senior management roles …
Vitaco Health Group lists on ASX
Vitaco Health Group—the company behind nutritional products including Aussie Bodies, Nutra-Life, Healtheries and Musashi—today made its debut on the ASX, positioning the company for the next phase of its growth. …
Terry White group announces profits, name change, outlook
Terry White Group Limited, the parent of pharmacy franchisors Terry White Management and Chemplus, has announced Net Profit After Tax of $1.2 million, on the back of a 16% increase …
CM exports to Asia more than double over past year
On the eve of the Vitafoods Asia expo in Hong Kong, one of the premier events for the global complementary medicines industry, Complementary Medicines Australia has welcomed the latest AusTrade …
ACCC okays Pfizer’s Hospira acquisition
The Australian Competition and Consumer Commission has announced that it will not oppose Pfizer Inc’s proposed $US17 billion acquisition of Hospira Inc. “Pfizer and Hospira are also the two largest …
Slade to purchase Fresenius Kabi oncology compounding business
Slade Pharmacy Services has entered into agreements with Fresenius Kabi to purchase its Oncology Compounding Business in Australia. This includes all the TGA-licenced compounding facilities in Queensland, NSW and Victoria. …
Novartis to acquire Spinifex, continue pain drug development
Novartis is to acquire Spinifex Pharmaceuticals, a company focused on the development of new drugs for treating chronic pain. Spinifex Pharmaceuticals, Inc. and its Australian subsidiary Spinifex Pharmaceuticals Pty Ltd, …
Sigma commits to another five years with Reform Management
Sigma Pharmaceuticals Limited has confirmed a new five-year wholesale supply and services agreement with Reform Management. With more than 1,900 independent community pharmacy customers nationally, Reform has one of the …